Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit

(2022) Acute Generalized Exanthematous Pustulosis following SARS-CoV-2 Virus: Remdesivir as a Suspected Culprit. CASE REPORTS IN MEDICINE. ISSN 1687-9627 1687-9635 J9 - CASE REP MED

Full text not available from this repository.

Abstract

Acute generalized exanthematous pustulosis (AGEP) is an exanthematous condition, predominantly occurring as a result of drug reactions. We, hereby, present the first case of AGEP following treatment with remdesivir in a patient with COVID-19, without hydroxychloroquine use, which serves as a reminder to consider remdesivir as a possible causative agent when dealing with AGEP presentation in COVID patients.

Item Type: Article
Keywords: AGEP
Journal or Publication Title: CASE REPORTS IN MEDICINE
Journal Index: ISI
Volume: 2022
Identification Number: https://doi.org/10.1155/2022/9880827
ISSN: 1687-9627 1687-9635 J9 - CASE REP MED
Depositing User: Zahra Otroj
URI: http://eprints.mui.ac.ir/id/eprint/16091

Actions (login required)

View Item View Item